Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07601672
PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Evaluation of OutcomeAIRC (Italian Association for Cancer Research)Not Yet RecruitingNot Applicable
NCT07601672Not Yet Recruiting
Not Applicable
PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Eva...AIRC (Italian Association...
NCT07601204
Treatment of Recurrent/Metastatic Head and Neck CancerShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Not Yet RecruitingPhase 1
NCT07601204Not Yet Recruiting
Phase 1
Treatment of Recurrent/Metastatic Head and Neck CancerShanghai Chia Tai Tianqin...
NCT07603310
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Patients.Hospital Dr. Franco Ravera ZuninoNot Yet RecruitingNot Applicable
NCT07603310Not Yet Recruiting
Not Applicable
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Pat...Hospital Dr. Franco Raver...
NCT07604103
Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza VaccinationUniversity of BrawijayaRecruitingPhase 3
NCT07604103Recruiting
Phase 3
Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomed...University of Brawijaya
NCT07601126
Respiratory Pathogen Distribution During and After the COVID-19 PandemicHisar Intercontinental HospitalCompleted
NCT07601126Completed
—
Respiratory Pathogen Distribution During and After the COVID-19 PandemicHisar Intercontinental Ho...
NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Eli Lilly and CompanyNot Yet RecruitingPhase 3
NCT07602582Not Yet Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAIL...Eli Lilly and Company
NCT07602738
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Al-Azhar UniversityCompletedPhase 3
NCT07602738Completed
Phase 3
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment fo...Al-Azhar University
NCT07603700
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary EmbolismNanjing First Hospital, Nanjing Medical UniversityNot Yet Recruiting
NCT07603700Not Yet Recruiting
—
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonar...Nanjing First Hospital, N...
NCT07604298
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic StrokeNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07604298Not Yet Recruiting
—
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Tre...Nanfang Hospital, Souther...
NCT07604480
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational StudyUniversity of Medicine and Pharmacy "Victor Babes" TimisoaraCompleted
NCT07604480Completed
—
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Pros...University of Medicine an...
NCT07602699
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Drug Abuse (NIDA)RecruitingPhase 2
NCT07602699Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Dru...
NCT07603102
Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive ImpairmentNanjing Mingzhou Rehabilitation HospitalRecruitingNot Applicable
NCT07603102Recruiting
Not Applicable
Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive ImpairmentNanjing Mingzhou Rehabili...
NCT07600944
Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single-Dose Subcutaneous Administration to Healthy VolunteersZhuhai United Laboratories Co., Ltd.RecruitingNot Applicable
NCT07600944Recruiting
Not Applicable
Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of...Zhuhai United Laboratorie...
NCT07603440
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)Assistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07603440Not Yet Recruiting
Phase 3
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy...Assistance Publique - Hôp...
NCT07601113
PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival StudyKun-Ming RauNot Yet Recruiting
NCT07601113Not Yet Recruiting
—
PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival StudyKun-Ming Rau
NCT07604454
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of LahoreCompletedNot Applicable
NCT07604454Completed
Not Applicable
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of Lahore
NCT07603375
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal AdenocarcinomaDuke UniversityNot Yet RecruitingPhase 2
NCT07603375Not Yet Recruiting
Phase 2
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Lo...Duke University
NCT07601282
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction SurgeryShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruiting
NCT07601282Recruiting
—
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary...Shanghai General Hospital...
NCT07603869
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026European Society of CardiologyCompleted
NCT07603869Completed
—
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2...European Society of Cardi...
Result Breakdown
Not yet recruiting9 (45%)
Completed6 (30%)
Recruiting5 (25%)
Not Specified8 (40%)
not_applicable5 (25%)
Phase 34 (20%)
Phase 22 (10%)
Phase 11 (5%)